Recruiting Chronic Myeloid Leukemia Studies in New York
Asciminib Roll-over Study
This is a long term safety study for patients who have completed a Novartis sponsored asciminib study and are judged by the investigator to benefit from continued treatment...
Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase
This study is a multicenter Phase 2, non-randomized, open-label single-group frontline study administering asciminib in patients with newly diagnosed Chronic Myeloid Leukemia-Chronic Phase (CML-CP). T...
Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation
This is a single arm phase II study that will enroll a minimum of 47 subjects with a maximum of 51. All patients will have a confirmed diagnosis of chronic phase chronic myeloid Leukemia and must have...
Study to Determine the Dose and Safety of Asciminib in Pediatric Patients With Chronic Myeloid Leukemia
The aim of this study is to support development of asciminib in the pediatric population (1 to \<18 years) previously treated with one or more TKIs. Full extrapolation of the efficacy of asciminib fro...
About Chronic Myeloid Leukemia Clinical Trials in New York
Chronic myeloid leukemia (CML) is a type of cancer that starts in blood-forming cells of the bone marrow, characterized by the Philadelphia chromosome and BCR-ABL fusion gene. It was one of the first cancers treated successfully with targeted therapy. Tyrosine kinase inhibitors like imatinib have transformed CML into a manageable chronic condition.
There are currently 4 chronic myeloid leukemia clinical trials recruiting participants in New York, NEW%20YORK. These studies are seeking a combined 542 participants. Research is being sponsored by Novartis Pharmaceuticals, Augusta University, Medical College of Wisconsin. Clinical trial participation is free and participants receive study-related medical care at no cost.
Chronic Myeloid Leukemia Clinical Trials in New York — FAQ
Are there chronic myeloid leukemia clinical trials in New York?
Yes, there are 4 chronic myeloid leukemia clinical trials currently recruiting in New York, NEW%20YORK. Browse the studies on this page to find one that fits.
How do I join a clinical trial in New York?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the New York research site will contact you about next steps.
Are clinical trials in New York free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many New York studies also compensate for your time and travel.
What chronic myeloid leukemia treatments are being tested?
The 4 active trials in New York are testing new therapies including novel drugs, biologics, and treatment approaches for chronic myeloid leukemia.
Data updated March 2, 2026 from ClinicalTrials.gov